The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / August / Can Blood Filtration Reduce PFAS?
Mass Spectrometry Clinical Spectroscopy Environmental News and Research

Can Blood Filtration Reduce PFAS?

Multi-platform analysis links therapeutic apheresis to reductions in circulating PFAS and selected plastic-associated signals  

08/20/2026 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Quiz
  • Topic Commentary

Share

Clinical Report: Can Blood Filtration Reduce PFAS?

Overview

Preliminary data suggest that therapeutic apheresis may reduce circulating PFAS levels alongside lipoproteins in patients. The study indicates that blood filtration techniques could address environmental contaminants.

Background

Per- and polyfluoroalkyl substances (PFAS) are persistent environmental pollutants linked to various health issues. Current clinical guidelines emphasize exposure reduction and screening rather than direct removal of PFAS from the body. Understanding the efficacy of blood filtration methods could provide insights into managing PFAS exposure.

Data Highlights

MeasurementReduction
PFOAUp to 25%
PFOSUp to 25%
PFNAUp to 25%
PFHxSUp to 25%

Key Findings

  • Therapeutic apheresis significantly reduced C-reactive protein, fibrinogen, LDL cholesterol, and lipoprotein(a) in 34 patients.
  • Independent laboratory analyses showed reductions in PFAS levels in patient samples, with one lab reporting up to 25% reduction in multiple PFAS compounds.
  • Polyethylene and polyvinyl chloride levels decreased in blood samples from patients undergoing treatment.
  • Raman spectroscopy indicated lower cholesterol- and lipid-associated spectral bands post-treatment.
  • Findings remain preliminary, with no established clearance mechanism for PFAS and microplastics.

Clinical Implications

The study indicates that therapeutic apheresis may reduce certain environmental contaminants in addition to its established use for lipid disorders. However, the clinical application of these findings is limited by the preliminary nature of the data.

Conclusion

Therapeutic apheresis shows reductions in PFAS levels in blood; further studies are necessary to confirm these findings.

Related Resources & Content

  1. Technische Universität Dresden, Source, 2024 -- Can Blood Filtration Reduce PFAS?
  2. ATSDR, Clinical Evaluation and Management: PFAS Information for Clinicians - 2024
  3. Substantial decrease of PFAS with anion exchange resin treatment - A clinical cross-over trial
  4. the analytical scientist — Portable PFAS Profiling
  5. the analytical scientist — Elevated PFAS Linked to Changes in Blood Lipids
  6. Archives of Toxicology — Concentrations of PFC/PFAS in Human Breast Milk and Infant Exposure via Lactation: An In-Depth Review of Existing Research
  7. the analytical scientist — Demystifying PFAS Testing
  8. Portable PFAS Profiling
  9. Elevated PFAS Linked to Changes in Blood Lipids
  10. Clinical Evaluation and Management: PFAS Information for Clinicians - 2024 | PFAS and Your Health | ATSDR
  11. Substantial decrease of PFAS with anion exchange resin treatment - A clinical cross-over trial - PubMed
  12. Extracorporeal Removal of Per- and Polyfluoroalkyl Substances by Hemoadsorption: In vitro Kinetic Model. | EBSCOhost

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

 This Week’s Mass Spec News
Mass Spectrometry
This Week’s Mass Spec News

April 4, 2025

2 min read

 What If Computers Could Smell?
Mass Spectrometry
What If Computers Could Smell?

April 3, 2025

13 min read

Computers can “see” and “hear,” but fully digitizing scent has so far eluded science – but that may soon change

The Analytical Scientist Innovation Awards 2024: #6
Mass Spectrometry
The Analytical Scientist Innovation Awards 2024: #6

December 3, 2024

3 min read

Syft Technologies’ William Pelet introduces the Syft Explorer – the world's first fully mobile, real-time, and direct trace gas analyzer

The Analytical Scientist Innovation Awards 2024: #4
Mass Spectrometry
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.